A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2001
11/08/2001	CA2418748A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
11/08/2001	CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2408105A1 Novel proteases
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407807A1 Stolonoxides
11/08/2001	CA2407799A1 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	CA2407797A1 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	CA2407796A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001	CA2407785A1 Use of .alpha.-msh and epo for preventing or treating ischemic conditions
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2407338A1 Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent
11/08/2001	CA2407225A1 Methods of producing membrane vesicles
11/08/2001	CA2407189A1 New gamma selective retinoids
11/08/2001	CA2407134A1 Cancer therapy
11/08/2001	CA2407132A1 Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine
11/08/2001	CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	CA2405363A1 Epitope synchronization in antigen presenting cells
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001	EP1152061A1 Development of method for screening physiologically active pyrrole imidazole derivative
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152057A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152009A1 Novel nucleosides and oligonucleotide analogues
11/07/2001	EP1151998A1 Estrogen agonists/antagonists
11/07/2001	EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus
11/07/2001	EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151083A1 Nitroreductase enzymes
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
11/07/2001	EP1151005A1 Peptide variants of the tumour marker muc1 and the use thereof
11/07/2001	EP1151002A1 Antibodies specific to kdr and uses thereof
11/07/2001	EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150995A1 A synthetic peptide disturbing intracellular signaling
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a)
11/07/2001	EP1150980A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
11/07/2001	EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
11/07/2001	EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150939A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer
11/07/2001	EP1150746A2 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
11/07/2001	EP1150714A2 Methods for inhibiting brain tumor growth
11/07/2001	EP1150712A2 Human papilloma virus vaccine formulations
11/07/2001	EP1150710A1 Immunogenic complexes and methods relating thereto
11/07/2001	EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150701A2 Homing pro-apoptotic conjugates and methods of using same
11/07/2001	EP1150697A1 High molecular weight extracts of convolvulus arvensis (field bindweed)
11/07/2001	EP1150696A2 Treatment of tumors with genetically engineered herpes virus
11/07/2001	EP1150692A2 Means for regulating hematopoietic differentiation
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150687A2 Methods for anti-tumor therapy
11/07/2001	EP1150683A1 Utilization of dienogest in high doses
11/07/2001	EP1150676A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP1011648B1 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/07/2001	EP0980205A4 Method of treating malignancies
11/07/2001	EP0912535B1 Conjugates of cis-docosahexaenoic acid and paclitaxel
11/07/2001	EP0879223B1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/07/2001	EP0835108B1 Use of lamellarin-class alkaloids in methods of treatment
11/07/2001	EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
11/07/2001	EP0726772B1 A method for sensitization of cancer cells for killer cell mediated lysis
11/07/2001	EP0707479B1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
11/07/2001	EP0600028B1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
11/07/2001	CN1321157A Substd. imidazo [1,2] azines as selective inhibitors of COX-2
11/07/2001	CN1321153A Telomerase inhibitors and method of their use
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321149A New crystal modification III of torasemide
11/07/2001	CN1321093A Method to enhance and confine expression of genes
11/07/2001	CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
11/07/2001	CN1320691A Polypeptide-human nucleotide reductase 9 and polynucleotide for coding it
11/07/2001	CN1320618A Polypeptide-human Pax protein 12.5 and polynucleotide for coding it
11/07/2001	CN1320617A Polypeptide-human Pax protein 14 and polynucleotide for coding it
11/07/2001	CN1320615A Polypeptide-human Pax protein 16 and polynucleotide for coding it
11/07/2001	CN1320614A Polypeptide-human translation initiation factor accessory factor 81 and polynucleotide for coding it
11/07/2001	CN1320613A Polypeptide-human ribosome S7 protein 14 and polynucleotide for coding it
11/07/2001	CN1320611A Polypeptide-cytokine receptor 15 and polynucleotide for coding it

1 ... 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 ... 2211